stockrow
Saturday 7 November 2026
Export OSRH’s income statement to Excel — free account
OSR Health, Inc.
OSRH Healthcare Biotechnology
OSR Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 million, down 17.7% from fiscal 2024.
- Revenue
- −72.2%
- EPS
- −200.0%
- Free cash flow
- −398.8%
- Total debt
- +28.2%
Quarter to June 2026, against a year earlier
0.15
0.01
+7.14%
Follow OSRH
Alert me
| Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | — | 0.10 | (0.59) |
P/S ratio |
— | — | — | — | 7.04 | 5.00 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | 3.85 | 1.04 |
P/FCF ratio |
— | — | — | — | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | — | — | (4.91) |
P/Operating CF |
— | — | — | — | (137.20) | (13.57) |
P/B ratio |
— | — | — | — | 0.17 | 0.11 |
Price to Tangible BV |
— | — | — | — | 0.00 | 0.00 |
EV/Sales |
— | — | — | — | 7.59 | 5.99 |
EV/EBITDA |
— | — | — | — | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | (14.49) | (4.02) |
EV/FCF |
— | — | — | — | (14.54) | (3.66) |
Quick Ratio |
0.20 | 0.01 | 0.10 | 0.01 | 0.37 | 0.12 |
Current Ratio |
0.20 | 0.01 | 0.10 | 0.01 | 0.67 | 0.16 |
Net Debt/EBITDA |
(9.97) | (1.58) | 3.04 | (0.03) | (0.98) | (0.29) |
Debt/Assets |
92.97% | 1.42% | 1.39% | 0.20% | 1.31% | 2.54% |
Debt/Equity |
250.00 | (4.76) | (0.45) | (0.02) | 0.02 | 0.03 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 |
Operating CF/Net income |
1.00 | 0.15 | 0.12 | (2.03) | 0.18 | 0.24 |
Capex/Depreciation |
— | — | — | — | 0.00 | (0.07) |
Interest Coverage |
— | — | — | — | (227.92) | (36.22) |
| 0.00% | 733.33% | 178.79% | (20.48%) | (14.83%) | (13.33%) | |
| 0.00% | (0.64%) | (3.67%) | 2.13% | (9.75%) | (10.40%) | |
ROIC |
0.00% | (66.53%) | 0.00% | 0.00% | (5.03%) | (8.84%) |
Return on Tangible Assets |
9.19% | 0.47% | 3.11% | (20.03%) | 910.52% | 127.02% |
Average Days of Receivables |
— | — | — | — | 96.55 | 49.25 |
Research and Development Expense of Revenue |
— | — | — | — | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 354.17% | 651.42% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.98 | 0.98 |
Share Based Compensation of Revenue |
— | — | — | — | 0.00% | 0.00% |
Graham Net Nets |
— | — | — | — | (1.20) | (2.85) |
Graham Number |
— | — | — | — | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | (27.65%) | (233.21%) |
Free Cash Flow Yield |
— | — | — | — | (7.42%) | (32.78%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 1.64 | 0.15 |
Operating CF per Share |
0.00 | 0.00 | 0.00 | (0.11) | (0.86) | (0.22) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.03) |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | (0.11) | (0.86) | (0.25) |
Cash per Share |
0.01 | 0.00 | 0.08 | 0.00 | 0.16 | 0.09 |
Shareholders Equity per Share |
0.00 | 0.00 | (0.02) | (0.51) | 66.45 | 6.51 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | (0.02) | (0.51) | 66.45 | 6.51 |
Free Cash Flow |
(0.02) | 0.00 | 0.00 | (0.82) | (1.84) | (4.94) |
Working Capital |
(0.26) | (0.70) | (1.14) | (2.02) | (1.14) | (14.35) |
Capital Expenditures |
— | — | — | — | 0.01 | (0.61) |
Net Current Asset Value |
(0.26) | (0.70) | (1.14) | (40.51) | (29.70) | (41.38) |
EV/EBIT |
— | — | — | — | 0.00 | 0.00 |
Capex to Sales |
— | — | — | — | 0.00 | 0.21 |
Price to Operating Income |
— | — | — | — | 0.00 | 0.00 |
| Other line items | ||||||
Depreciation/Fixed assets |
— | — | — | — | 4,213.04 | 55.03 |
Cash ROIC |
(6.54%) | (3.94%) | (4.04%) | 21.44% | (1.26%) | (3.71%) |
Accounts Receivable Turnover |
— | — | — | — | 0.00 | 4.38 |
Accounts Payable Turnover |
— | — | 0.00 | 0.00 | 2.52 | 0.52 |
Inventory Turnover |
— | — | — | — | 0.00 | 4.14 |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 144.81 | 1,235.67 |
Days of Inventory on Hand |
— | — | — | — | 123.78 | 30.99 |
Average Receivables |
— | — | — | — | — | 0.66 |
Average Payables |
— | — | 0.02 | 0.56 | 1.08 | 4.45 |
Average Inventory |
— | — | — | — | — | 0.56 |
Average Assets |
— | 0.51 | 0.97 | 18.93 | 105.93 | 173.24 |
Average Common Equity |
— | 0.00 | (0.02) | (1.97) | 69.65 | 135.12 |
Columns are period end dates · fundamentals updated 26 Oct 2026